ProDeMaCon’s proprietary MatRisk™, our phase-appropriate Material & Supplier Management system, has already been successfully implemented at several CGT companies and CDMOs. Whether you are in early development or already in pivotal trials, it’s crucially important to plan for proper raw material onboarding & qualification while ensuring continuity of supply. Your Pharma, Biotech or Cell&Gene business depends on it.
For more information on the importance of proper Material & Supplier Management in Cell&Gene but also in Biotech, refer to our recently published article:
Best Practices For Raw Material And Supplier Management For Cell & Gene Therapy Manufacturing By Andreas M. Beckhaus and David J. Cady
Contact us for more information on MatRisk™.
During the BoM-Lock™ exercise, all raw materials (excipients, primary containers, starting materials such as vectors, reagents, buffers, single-use components etc.) on your Bill of Materials (BoM) are ranked by criticality to
The BoM-Lock™ tool lets you easily prioritize your critical material activities to do the right thing at the right time
The MatMap™ tool takes into account your timelines for First-in-Human, Pivotal Trial start, PPQ runs and IND and BLA filing plans etc. It will help you plan and budget phase-appropriately, identify critical tasks and dependencies for example for your testing plans. MatMap™ also helps you plan your resource needs by discipline over time for all material- and supplier-related activities.
The raw material assessment form of the MatRisk™ toolbox is a "living" form that documents the phase-appropriate risk assessment for each material used in GMP production, considering among others:
Following Quality by Design (QbD) principles, potential Critical Material Attributes are determined for your Material Qualification and own testing plan as well as other attributes where you may rely on manufacturer testing.
Based on the draft Critical Material Attributes from the initial risk assessment, a testing plan is put together for your Material Qualification to transition from clinical specification to commercial specification.
Test results (typically from 3 different material batches) are documented and evaluated (e.g., by comparing your results with the manufacturer's CoA and vs. your own process needs) in the Material Qualification form, which will serve as the justification for your commercial specification.
SupRisk™, the Supply Continuity tool of MatRisk™, will assess the available capacity, regulatory/quality maturity, and financial health of your suppliers. It will also assess for each raw material:
This lets you easily prioritize your critical materials and suppliers in order to take appropriate actions such as SRM (Supplier Relationship Management), Inventory management, second sourcing, alternative sourcing etc.
The SOP and policy templates from the MatRisk™ toolbox can easily be adapted and implemented according to your needs. They specify all necessary activities for material and supplier management phase-appropriately over the life cycle of the product. They work in conjunction with the other tools of the MatRisk™ toolbox.
Additional complementary template forms from the MatRisk™ toolbox include:
ProDeMaCon: Product Development and Marketing Consulting, LLC, San Francisco, CA, USA
© 2024 ProDeMaCon LLC - All Rights Reserved.